CNSX:HUGE - FSD Pharma Stock Price, News & Analysis

0.00 (0.00 %)
(As of 08/23/2019 06:00 AM ET)
Today's Range
Now: $0.11
50-Day Range
MA: $0.13
52-Week Range N/A
Volume969,049 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
FSD Pharma Inc operates as a cannabis company in Canada. It is involved in hydroponic indoor cannabis production and processing activities. The company, through its subsidiary, FV Pharma Inc, holds license to produce marijuana under the Access to Cannabis for Medical Purposes Regulations. It has a strategic alliance agreement with SciCann Therapeutics Inc for the production and distribution of cannabinoid-based, patent pending, and indication-specific products developed by SciCann Therapeutics Inc The company was formerly known as Century Financial Capital Group Inc and changed its name to FSD Pharma Inc in May 2018. Read More…

Industry, Sector and Symbol

Industry Software - Application
SectorComputer and Technology



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive HUGE News and Ratings via Email

Sign-up to receive the latest news and ratings for HUGE and its competitors with MarketBeat's FREE daily newsletter.

FSD Pharma (CNSX:HUGE) Frequently Asked Questions

What is FSD Pharma's stock symbol?

FSD Pharma trades on the CNSX under the ticker symbol "HUGE."

Has FSD Pharma been receiving favorable news coverage?

Media coverage about HUGE stock has been trending positive this week, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. FSD Pharma earned a news sentiment score of 2.5 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the stock's share price in the near future. View News Stories for FSD Pharma.

Who are some of FSD Pharma's key competitors?

What other stocks do shareholders of FSD Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other FSD Pharma investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Canopy Growth (WEED), Cannara Biotech (LOVE), Aphria (APHA), Lithium Americas (LAC), AutoCanada (ACQ), Bombardier, Inc. Class B (BBD.B), Emerald Bay Energy (EBY) and Solarvest Bioenergy (SVS).

How do I buy shares of FSD Pharma?

Shares of HUGE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is FSD Pharma's stock price today?

One share of HUGE stock can currently be purchased for approximately $0.11.

MarketBeat Community Rating for FSD Pharma (CNSX HUGE)

Community Ranking:  3.7 out of 5 (star star star)
Outperform Votes:  169 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  230
MarketBeat's community ratings are surveys of what our community members think about FSD Pharma and other stocks. Vote "Outperform" if you believe HUGE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUGE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/23/2019 by Staff

Featured Article: Cryptocurrencies

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel